Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg, South Africa

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages 1-

  Umanah, Teye ^a   Ncayiyana, Jabulani ^a,b   Padanilam, Xavier ^c   Nyasulu, Peter S ^a,d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b University of North Carolina at Chapel Hill   (United States)

^c Sizwe Tropical Diseases Hospital   (South Africa)

^d MONASH UNIVERSITY   (Australia)

Author keywords

'Timing of ART initiation before or after commencement of MDR TB treatment'; MDR TB HIV treatment adherence; Mortality; Treatment failure

Indexed keywords

AMIKACIN; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; ETHAMBUTOL; ETHIONAMIDE; KANAMYCIN; MOXIFLOXACIN; PYRAZINAMIDE; TERIZIDONE; TUBERCULOSTATIC AGENT;

ADULT; ADVERSE DRUG REACTION; AGED; ANEMIA; ARTHRALGIA; ARTICLE; CLINICAL FEATURE; CONJUNCTIVITIS; DEPRESSION; DISEASE SEVERITY; DRUG TREATMENT FAILURE; DRUG USE; FACTORIAL ANALYSIS; FEMALE; GYNECOMASTIA; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERURICEMIA; HYPOTHYROIDISM; LIVER TOXICITY; LUNG CAVITY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; NAUSEA AND VOMITING; NEPHROTOXICITY; OPPORTUNISTIC INFECTION; OTOTOXICITY; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PREDICTION; PSYCHOSIS; RETROSPECTIVE STUDY; SIDE EFFECT; SOUTH AFRICA; THORAX RADIOGRAPHY; TREATMENT RESPONSE; TROPICAL DISEASE; UNDERWEIGHT; CHI SQUARE DISTRIBUTION; COINFECTION; COMORBIDITY; HIV INFECTIONS; STATISTICAL MODEL; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADULT; ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; COINFECTION; COMORBIDITY; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES; SOUTH AFRICA; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84945953936     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-1214-3     Document Type: Article

References (34)

1. World Health Organisation. Global Tuberculosis Report-2014. Geneva: WHO; 2014.
2. World Health Organisation. Global Tuberculosis Report - 2013 (WHO/HTM/TB/2013.11). Geneva: WHO; 2013.
3. World Health Organization (WHO). Multidrug and extensively drug-resistant TB (M/XDR-TB):2010 global report on the surveillance and response. Geneva: WHO; 2010.
4. Seung KJ, Omatayo DB, Keshavjee S, Furin JJ, Farmer PE, Satti H. Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa. PLoS One. 2009;4(9), e7186.
5. Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis. 2007;196 Suppl 1:S86-107.
6. Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G, Tugela Ferry C, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. J Infect Dis. 2007;196 Suppl 3:S482-490.
7. Hopewell P, Bloom B. Tuberculosis and other Mycobacterial diseases. In: Murray J, JA N, editor. Respiratory Medicine. Philadelphia, PA: WB Saunders Company; 2000. p. 1043-105.
8. Kendon M, Knight SE, Ross A, Giddy J. Timing of antiretroviral therapy initiation in adults with HIV-associated tuberculosis: Outcomes of therapy in an urban hospital in KwaZulu-Natal. S Afr Med J. 2012;102:931-5.
9. Palacios E, Franke M, Munoz M, Hurtado R, Dallman R, Chalco K, et al. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era. Int J Tuberc Lung Dis. 2012;16(3):348-54.
10. Waisman JL, Palmero DJ, Alberti FA, Guemes Gurtubay JL, Francos JL, Negroni R. Improved prognosis in HIV/AIDS related multi-drug resistant tuberculosis patients treated with highly active antiretroviral therapy. Medicina. 2001;61(6):810-4.
11. Isaakidis P, Cox HS, Varghese B, Montaldo C, Da Silva E, Mansoor H, et al. Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai. India PLoS One. 2011;6(12), e28066.
12. Satti H, McLaughlin MM, Hedt-Gauthier B, Atwood SS, Omotayo DB, Ntlamelle L, et al. Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho. PLoS One. 2012;7(10), e46943.
13. World Health Organisation. Guidelines for the programmatic management of drug-resistant tuberculosis-2008 (WHO/HTM/TB/2008.402). Geneva: WHO; 2008.
14. Department of Health South Africa: Management of drug-resistant tuberculosis- Policy Guidelines - Updated 2013. Pretoria: Department of Health; 2013.
15. World Health Organisation: Guidelines for the programmatic management of drug-resistant tuberculosis-2011 Update. Geneva: WHO; 2011.
16. World Health Organization. Definitions and reporting framework for tuberculosis - 2013 revision. Geneva: WHO; 2013.
17. Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2009;4(9), e6914.
18. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcantara F, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med. 2003;348(2):119-28.
19. Leimane V, Riekstina V, Holtz TH, Zarovska E, Skripconoka V, Thorpe LE, et al. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. The Lancet. 2005;365(9456):318-26.
20. Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, et al. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med. 2006;144(9):650-9.
21. Yew WW, Chan CK, Chau CH, Tam CM, Leung CC, Wong PC, et al. OUtcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens. CHEST Journal. 2000;117(3):744-51.
22. Leimane V, Dravniece G, Riekstina V, Sture I, Kammerer S, Chen MP, et al. Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004. Eur Respir J. 2010;36(3):584-93.
23. Brust JC, Berman AR, Zalta B, Haramati LB, Ning Y, Heo M, et al. Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry. South Africa PLoS One. 2013;8(9), e73975.
24. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med. 1995;151(1):129-35.
25. Sharma SK, Mohan A, Kadhiravan T. HIV-TB co-infection: epidemiology, diagnosis & management. Indian J Med Res. 2005;121(4):550-67.
26. Anderson L, Tamne S, Watson J, Cohen T, Mitnick C, Brown T, et al. Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. Eur Commun Dis Bull 2013, 18(40)
27. Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, et al. Aggressive Regimens for Multidrug-Resistant Tuberculosis Decrease All-Cause Mortality. PLoS One. 2013;8(3), e58664.
28. Restrepo BI, Fisher-Hoch SP, Crespo JG, Whitney E, Perez A, Smith B, et al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect. 2007;135(3):483-91.
29. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7), e152.
30. Young F, Critchley J, Johnstone L, Unwin N. A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization. Global Health. 2009;5(1):9.
31. Feve B, Glorian M, Hadri KE. Pathophysiology of the HIV-Associated Lipodystrophy Syndrome. Metab Syndr Relat Disord. 2004;2(4):274-86.
32. Pablos-Méndez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health. 1997;87(4):574-9.
33. Kang YA, Kim SY, Jo KW, Kim HJ, Park SK, Kim TH, et al. Impact of diabetes on treatment outcomes and long-term survival in multidrug-resistant tuberculosis. Respiration. 2013;86(6):472-8.
34. Choi H, Lee M, Chen RY, Kim Y, Yoon S, Joh JS, et al. Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012. BMC Infect Dis. 2014;14:360.